NasdaqGM:LMATMedical Equipment
What LeMaitre Vascular (LMAT)'s Strong Quarter But Softer Guidance Means For Shareholders
Earlier this month, LeMaitre Vascular reported quarterly revenues of US$66.55 million, an 11.2% year-on-year increase, alongside an earnings beat versus analyst expectations, but paired this with comparatively weaker full-year guidance than its peer group.
Management is also actively engaging investors through recent and upcoming appearances at major healthcare conferences hosted by Bank of America, Jefferies, and Goldman Sachs, signaling a focus on explaining the company’s outlook and...